{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:23:17Z","timestamp":1750357397548},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.numecd.2012.04.016","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T11:59:20Z","timestamp":1340798360000},"page":"613-618","source":"Crossref","is-referenced-by-count":21,"title":["Treatment of diastolic dysfunction in hypertension"],"prefix":"10.1016","volume":"22","author":[{"given":"P.","family":"Ginelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.N.","family":"Bella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.numecd.2012.04.016_bib1","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.0000015076.37047.D9","article-title":"Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the strong heart study","volume":"105","author":"Bella","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.numecd.2012.04.016_bib2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0735-1097(01)01110-X","article-title":"Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study","volume":"37","author":"Aurigemma","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2012.04.016_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.numecd.2012.04.016_bib4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"J Am Med Assoc"},{"issue":"12","key":"10.1016\/j.numecd.2012.04.016_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0735-1097(02)01896-X","article-title":"Prognostic significance of left ventricular diastolic dysfunction in essential hypertension","volume":"39","author":"Schillaci","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2012.04.016_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.numecd.2012.04.016_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2012.04.016_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.numecd.2012.04.016_bib9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.1996.00440150033003","article-title":"The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview","volume":"156","author":"Vasan","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2012.04.016_bib10","series-title":"Molecular mechanisms of cardiac hypertrophy and failure","first-page":"477","article-title":"Epidemiology of left ventricular hypertrophy and dilated cardiomyopathy","author":"Bella","year":"2005"},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","article-title":"Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999\u20132004","volume":"52","author":"Cutler","year":"2008","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.numecd.2012.04.016_bib12","first-page":"1462","article-title":"Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (esh) and of the European society of cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.numecd.2012.04.016_bib13","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"289","author":"Chobanian","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.numecd.2012.04.016_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.numecd.2012.04.016_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2012.04.016_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/hc0902.104599","article-title":"Change in diastolic left ventricular filling after one year of antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension (life) study","volume":"105","author":"Wachtell","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.numecd.2012.04.016_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.numecd.2012.04.016_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004872-200102000-00018","article-title":"Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial","volume":"19","author":"Terpstra","year":"2001","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/hrt.2007.117978","article-title":"The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction","volume":"94","author":"Yip","year":"2008","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.numecd.2012.04.016_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.amjhyper.2006.02.009","volume":"19","author":"Muller-Brunotte","year":"2006","journal-title":"Am J Hypertens"},{"issue":"9579","key":"10.1016\/j.numecd.2012.04.016_bib21","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(07)60980-5","article-title":"Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial","volume":"369","author":"Solomon","year":"2007","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.numecd.2012.04.016_bib22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"issue":"9386","key":"10.1016\/j.numecd.2012.04.016_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.numecd.2012.04.016_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.amjcard.2010.05.032","article-title":"Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE study)","volume":"106","author":"Wachtell","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2012.04.016_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-117-6-502","article-title":"Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management","volume":"117","author":"Bonow","year":"1992","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.numecd.2012.04.016_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1388-9842(03)00054-0","article-title":"Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol","volume":"5","author":"Nodari","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.numecd.2012.04.016_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.numecd.2012.04.016_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9149(97)00320-2","volume":"80","author":"Aronow","year":"1997","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2012.04.016_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjcard.2004.05.004","article-title":"Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction","volume":"94","author":"Takeda","year":"2004","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00001573-199909000-00003","article-title":"Treatment of the hypertensive patient with microvascular angina","volume":"14","author":"Ventura","year":"1999","journal-title":"Curr Opin Cardiol"},{"issue":"17","key":"10.1016\/j.numecd.2012.04.016_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2009.11.084","article-title":"Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (anglo-scandinavian cardiac outcomes trial) substudy","volume":"55","author":"Tapp","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.numecd.2012.04.016_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0002-9149(90)90937-V","article-title":"Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance","volume":"66","author":"Setaro","year":"1990","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2012.04.016_bib34","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"19","key":"10.1016\/j.numecd.2012.04.016_bib35","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"112","author":"Izawa","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2012.04.016_bib37","unstructured":"http:\/\/www.topcatstudy.com [accessed 29.09.11]."},{"issue":"5","key":"10.1016\/j.numecd.2012.04.016_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ajh.2010.235","article-title":"Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient","volume":"24","author":"Galderisi","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2012.04.016_bib39","article-title":"Role of ACE2 in diastolic and systolic heart failure","author":"Wang","year":"2011","journal-title":"Heart Fail Rev"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:14:04Z","timestamp":1561886044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475312001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0939475312001287"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2012.04.016","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}